Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 312,837 shares at $69.74 ($895K) on 2026-06-01, disclosed to the SEC on 2026-06-02.
Scheduled sale ($895k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 300,000 | $0 | 0.0% |
| 2 | $69.74 | 12,837 | $895K | 100.0% |
| Total | $2.86 avg | 312,837 | $895K | 100% |
| Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |
| CORT | SELL | 2025-10-03 | $6.8M | — | Filing → |